Preferred Name |
bicalutamide |
|
Synonyms |
ICI 176334 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C053541 |
|
altLabel |
ICI 176334 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide Casodex Cosudex ICI-176334 Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-, (+-)- |
|
cui |
C0591237 C0740019 C0285590 |
|
HM |
D000813 D014105 D009570 |
|
Inverse of RB |
A0Z3NAU9DP |
|
isa | ||
LT |
TRD |
|
Mapped to |
http://purl.bioontology.org/ontology/MESH/D009570 |
|
MDA |
19871009 |
|
MeSH Frequency |
1208 |
|
MMR |
20161222 |
|
notation |
C053541 |
|
PA |
D000726 D000970 |
|
prefLabel |
bicalutamide |
|
RR |
90357-06-5 |
|
SC |
1 |
|
Scope Statement |
approved for treatment of advanced prostate cancer |
|
SRC |
J Endocrinol 1987;113(3):R7 |
|
TERMUI |
T181655 T181656 T181658 T181654 T181657 T622576 |
|
TH |
MX UK NL CA NLM (1987) ES INN (19XX) DE AU FDA SRS (2015) USAN (1987) FR IE |
|
tui |
T109 T121 |
Create mapping